Contact Pharmacy Practice and Administration

Chair: Jack Brown
Email: jbrown@sjfc.edu
Office: WEGPHR 315
Phone: (585) 385-7208

Faculty & Staff Detail

Judianne Slish, Pharm.D., BCPS

Title: Associate Professor
Office: WEGPHR 234
Phone: (585) 385-7377
Email: jslish@sjfc.edu
Education: Pharmacy Practice Residency, Strong Memorial Hospital (Rochester NY)
PGY2 Infectious Diseases Mayo Clinic Rochester MN
Pharm.D., University of Buffalo
B.S.Pharm., University of Buffalo


Slish_Judianne.jpg

Dr. Slish received her B.S. in Pharmacy and Pharm.D. from the State University of New York at Buffalo. She completed a PGY-1 residency at the University of Rochester Medical Center, and PGY-2 residency in Infectious Diseases at the Mayo Clinic-Rochester Minnesota. After completion of her residency, she was an Assistant Professor at the State University of New York at Buffalo with a clinical site at Erie County Medical Center for six years prior to joining the Wegmans School of Pharmacy.

In 2007, Dr. Slish joined the Wegmans School of Pharmacy as an Associate Professor of Pharmacy Practice.

Dr. Slish provides clinical pharmacy services and precepts fourth year pharmacy students at Highland Hospital in Rochester, NY. She is part of the Infectious Disease consult service. She has been highly involved within pharmacy organizations and advocacy, and has been the past president of Pharmacist Association of Western New York and Pharmacist Society of the State of New York. Dr. Slish holds many memberships in multiple state and national pharmacy organizations.

Dr. Slish’s research interests include antibiotic stewardship, clostridium difficile, antibiotic use in bone cement, and HIV/HCV drug interactions.

Publications

  • Slish JC, Rightmier, E, Catanzaro, LM. Antiretroviral Agents. Lamivudine. In Yu VL. Edwards G, McKinnon PS, Peloquin C, Morse GD (Eds.), Antimicrobial Therapy and Vaccines; Volume II Update 2014-In Press.
  • Slish, JC. New York State Pharmacist Century II; Presidents Message, May/June 2013; 87(3):4.
  • Slish, JC. New York State Pharmacist Century II; Presidents Message, March/April 2013; 87(2): 4-5.
  • Slish, JC. New York State Pharmacist Century II; Presidents Message, January/February 2013; 87(1):4-5.
  • Mark Shelly, Judianne Slish, Mellissa Schiff, Bruce Goldman and Allen Boyd. Renal Toxicity Related to Aminoglycoside-Containing Orthopedic Cement. The Journal of Arthroplasty. Submitted for review December 2012-rejected.
  • Rightmier, E Slish JC. Antiretroviral Agents: Emtricitabine. In Yu VL, Edwards G, McKinnon PS, Peloquin C, Morse GD. (Ed/s.), Antimicrobial Therapy and Vaccines Volume II; Antimicrobial Agents, Baltimore: Williams and Wilkins. September 2012-In Press.
  • Slish, JC. New York State Pharmacist Century II; Presidents Message, November/December 2012; 86(6):4.
  • Slish, JC. New York State Pharmacist Century II; Presidents Message, September/October 2012; 86(5):4.
  • Slish, JC. New York State Pharmacist Century II; Presidents Message, July/August 2012; 86(4): 4,8.
  • Catanzaro LM, Pollard RB, Shafer R, Slish JC, Alkebulan AD, Morse GD. Antiretroviral Agents. Lamivudine. In Yu VL. Edwards G, McKinnon PS, Peloquin C, Morse GD (Eds.), Antimicrobial Therapy and Vaccines; Volume II Update 2009.
  • Higgins N, Zingman BS, Slish J, Reichman RC, Fischl MA, Gripshover B, Tooley K, Boston N, Forrest A, Brazeau D, Catanzaro LM, DiFrancesco R, Lliguicota F, Ma Q, Morse GD. Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir. American Journal on Addictions 2007 Nov-Dec;16(6):488-94.
  • Ma Q, Brazeau D, Zingman B, Reichman R, Fischl M, Gripshover B, Venuto C, Slish J, DiFrancesco R, Forrest A, Morse GD. Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV. Pharmacogenomics 2007; 8(3):227-235.
  • Slish J, Ma Q, Zingman BS, Reichman RC, Fischl MA, Gripshover B, Forrest A, Brazeau D, Boston NS, Catanzaro L, DiFrancesco R, Morse GD. Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring. Therapeutic Drug Monitoring 2007 Oct;29(5):560-5.
  • Slish, JC. PAWNY Express Newsletter, Presidents Message, September-October 2007, pages 1 and 3.
  • Slish, JC. PAWNY Express Newsletter, Presidents Message, July-August 2007, pages 1 and 3.
  • Maponga CC, Slish JC, Ma, Q, Morse GD. HIV Pharmacotherapy Issues, Challenges, and Priorities in Sub-Saharan African Countries. Topics in HIV Medicine 2007, June/July; 15(3).
  • Slish, JC. PAWNY Express Newsletter, Presidents Message, May-June 2007, page 9.
  • J.C. Slish, L.M. Catanzaro, Q. Ma, O.O. Okusanya, L. Demeter, M. Albrecht and G.D. Morse. Update on the Pharmacokinetic Aspects of Antiretroviral Agents: Implications in Therapeutic Drug Monitoring. Current Pharmaceutical Design 2006; 12(9):1129-1145.
  • Qing Ma, ­Olanrewaju O Okusanya, ­Patrick F Smith, ­Robert DiCenzo, ­Judianne C Slish, ­Linda M Catanzaro, ­Alan Forrest & ­Gene D Morse?‌. ­Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors. Expert Opinion on Drug Metabolism & Toxicology October 2005; 1(3): 473-485.
  • Judianne C. Slish, Linda M. Catanzaro, Qing Ma, Olanrewaju Okusanya, Lisa M Demeter, Mary Albrecht, Robin DiFrancesco, Gene. D. Morse. Therapeutic Drug Monitoring: Role for a Pharmacist in a Multidisciplinary Antiretroviral Management. Journal of Pharmacy Practice 2005; 18(4): 310-321.
  • Naomi Boston, Judianne C. Slish. Management of HIV Infection in Persons Co-infected with Hepatitis. Journal of Pharmacy Practice 2005; 18(4): 295-309.
  • Slish JC, Crumpacker CS, Antoniou T. Ganciclovir. In Yu VL, Edwards G, McKinnon PS, Peloquin C, Morse GD.(Ed/s.), Antimicrobial Therapy and Vaccines Volume II; Antimicrobial Agents, Baltimore: Williams and Wilkins. 2005.
  • Catanzaro LM, Pollard RB, Shafer R, Slish JC, Alkebulan AD, Morse GD. Antiretroviral Agents: Lamivudine, Emtricitabine. In Yu VL, Edwards G, McKinnon PS, Peloquin C, Morse GD.(Ed/s.), Antimicrobial Therapy and Vaccines Volume II; Antimicrobial Agents, Baltimore: Williams and Wilkins. 2005.
  • Linda M. Catanzaro, Pharm.D. Judianne C. Slish, Pharm.D. Robert DiCenzo, Pharm.D., and Gene D. Morse, Pharm.D. Drug Interactions with Antiretrovirals, Current Reports. 2004;1(2):89-96.
  • DiCenzo R, Forrest A, Slish JC, Cole C and Guillet R. A Gentamicin Pharmacokinetic Population Model and Once-Daily Dosing Algorithm for Neonates. Pharmacotherapy 2003;23(5):579-584.

Awards & Honors

  • Chairman's Award 2014
  • PSSNY Excellence in Post Graduate Education 2014
  • Nominated-Preceptor of the Year at Practice site 2014
  • Kappa Psi Recognition Button 2012
  • Strathmore's Who's Who 2012
  • NCPA Pharmacy Leadership Award 2012
  • Service to PSSNY and PAWNY Award 2012
  • McKesson Corporation Leadership Award 2012
  • CAPS Enabler Award 2011
  • Kappa Psi Certificate of Commendation (W. Bruce Phillip) 2006
  • Kappa Psi Recognition Button 2000
  • University at Buffalo School of Pharmacy Ambulatory Care Professional Experience Program Award 1999
  • WNYSHP Commitment to Hospital Pharmacy Award 1999

Presentations Invited

  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, April 2014.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, January 2014.
  • Delivery of Medication Therapy Management Services in the Community Certificate Program. PSSNY Midwinter Convention, January 2014.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, November 2013.
  • Pharmacy-Based Immunization Delivery Certificate Program. PSSNY, Albany NY, October 2013.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, June 2013.
  • Delivery of Medication Therapy Management Services in the Community Certificate Program. PSSNY Annual Convention, June 2013.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, May 2013.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, January 2013.
  • "What's new in HIV Therapy, Update of the Guidelines" ACPE continuing education program for pharmacists. KY alumni Pharmacists. Buffalo, NY, April 2013.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, October 2011.
  • Pharmacy-Based Immunization Delivery Certificate Program. PSSNY Annual Convention, June 2011.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, June 2011.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, April 2011.
  • Pharmacy-Based Immunization Delivery Certificate Program. PSSNY Midwinter Convention, January 2011.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, October 2010.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, April, 28 2010.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, April 22, 2010.
  • "Update in HIV" ACPE continuing education program for pharmacists, Pharmacists Association of Western New York, Buffalo, NY, January 2010.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, July 2009.
  • Pharmacy-Based Immunization Delivery Certificate Program. St. John Fisher College, May 2009.
  • "Update in the Management of HIV, Mastering the Therapeutic Management." Lecture.
  • Making a Difference in Infectious Diseases Pharmacotherapy, Orlando, FL May 2008.
  • "New Treatments for Patients with HIV Infections" ACPE six series teleconference continuing education program for the Schentag Cooperation. January 2008-April 2008.
  • "Infectious Diseases: A Focus on The Identification and Treatment of Sexually Transmitted Diseases." ACPE continuing education program for KY alumni Pharmacists. Buffalo, NY, May 2007.
  • "Managing your Antiretroviral Formulary: How to treat the Naïve and Treatment Experienced Patient." Workshop, Making a Difference in Infectious Diseases Pharmacotherapy, Orlando, FL, May, 2007.
  • "Advances in HIV Therapy, Dealing with HIV Medication errors" Lecture, Making a Difference in Infectious Diseases Pharmacotherapy, Orlando, FL, May, 2007.
  • "Sexually Transmitted Diseases." ACPE continuing education program for pharmacists. Pharmacists' Association of Western New York; Buffalo, NY, April 2007.
  • "Therapeutic Drug Monitoring of Antiretrovirals;" Inservice, University of Ottawa; Ottawa, Ontario, December, 2006.
  • "HIV Pharmacotherapy Update" ACPE continuing education program for pharmacists. Kappa Psi Province V Midyear Conference; Buffalo, NY, October 2006.
  • "Break-Out Session: Patient Counseling, Data Collection." Introductory HIV Pharmaceutical Care Specialist Certificate Program – Case Study Work Shop, UB School of Pharmacy and Pharmaceutical Sciences; San Diego, CA, April 2005.
  • "Antiretroviral Medications Update." Introductory HIV Pharmaceutical Care Specialist Certificate Program – Case Study Work Shop, UB School of Pharmacy and Pharmaceutical Sciences; San Diego, CA. April 2005.
  • "Antiretroviral Medications Update." ACPE continuing education program for pharmacists. HIV Pharmacotherapy Update, UB School of Pharmacy and Pharmaceutical Sciences; Buffalo, NY November, 2004.
  • "Update on Recent Clinical Trials for Hepatitis C and HIV Co-infection." Inservice, Erie County Medical Center, Immunodeficiency Clinic; Buffalo, NY, November 2004.
  • "Opportunistic Infections in AIDS" Lecture, Physician Assistant Students, PA Pharmacology II – D'Youville College; Buffalo, NY October 2004.
  • "Managing Side Effects Associated with Antiretrovirals." Pennsylvania Society of Health-System Pharmacists Midyear Meeting XXV; Pittsburgh, PA, March 11-12, 2004. "HIV Update." ACPE continuing education program for pharmacists. Pharmacists' Association of Western New York; Buffalo, NY, February 2004.
  • "Opportunistic Infections in AIDS." Lecture, Physician Assistant Students, PA Pharmacology II D'Youville College, December 2003.
  • "Sexually Transmitted Diseases." ACPE continuing education program for pharmacists. Women's Health Symposium, UB School of Pharmacy and Pharmaceutical Sciences; Buffalo, NY, November 18, 2003.
  • "Opportunistic Infections in AIDS." Lecture, Physician Assistant Students, PA Pharmacology II D'Youville College, October 2002.
  • "Hormone Replacement Therapy." Lecture, Physician Assistant Students, PA Pharmacology II D'Youville College, May 2001."Menstrual Disorders."
  • "Menstrual Disorders." Lecture, Physician Assistant Students, PA. Pharmacology II D'Youville College, May 2001.
  • "Hypertension." Lecture, Graduate School of Nursing, St. John Fisher College, November 2000.
  • "Congestive Heart Failure." Lecture, Graduate School of Nursing, St. John Fisher College, November 2000.
  • "Thyroid disorders and Treatment." Lecture, Physician Assistant students, PA Clinical Pharmacology I course – Rochester Institute of Technology, September 2000.
  • "Current Concepts in the Treatment of Attention Deficit Hyperactivity Disorder." A two-hour ACPE continuing education program for pharmacists – UB School of Pharmacy Alumni, May 2000.
  • "Current Concepts in the Treatment of Attention Deficit Hyperactivity Disorder." A two-hour ACPE continuing education program for pharmacists – Kappa Psi Pharmaceutical Fraternity; Buffalo, NY, March 2000.

Posters/Platform Presentations

  • Tim Adler, Judianne C. Slish, Mark Shelly. Acute Kidney Injury Related to Antibiotic-Impregnated Orthopedic Cement. ASHP Clinical Midyear Meeting. Anaheim, CA. December 7-11, 2014. Poster.
  • Mark Shelly M.D., Tim Adler, Pharm.D. Candidate, Judianne C. Slish, Pharm.D., Acute Kidney Injury Related to Antibiotic-Impregnated Orthopedic Cement. Infectious Diseases Society of America Annual Meeting, Philadelphia, PA. October 2014. Platform Presentation.
  • Will Bossard, Judianne C. Slish, Jill E. Lavigne, Jeremy Siehnel, Na Li, and Elizabeth Rightmier. Adherence to Clostridium difficile Infection Institutional Treatment Guideline at Highland Hosptial. ASHP Clinical Midyear Meeting. Orlando, FL. December 8-12, 2013.
  • What you need to know about Prosthetic Joint Infections." Inservice, Department of Pharmacy, Highland Hospital. December 2012.
  • "I-STOP Legislation." Inservice Department of Medicine, Highland Hospital, November 2012.
  • "Vitamins and Supplements available at Highland Hospital" Inservice, Department of Nutrition, Highland Hospital, April 2012.
  • "Gastric Bypass and Vitamin supplementation" Inservice, Department of Nutrition, Highland Hospital, April 2012.
  • "C. Diff Protocol." Inservice, Department of Medicine, Highland Hospital, November 2011.
  • Mark Shelly, Judianne Slish, Lynne Brown, Polly Moore, Melissa Schiff, and Gail Quinlan. Renal Toxicity Related to Antibiotic-Containing Orthopedic Cement. Infectious Diseases Society of America Annual Meeting, Boston, Massachusetts September 2011.
  • Angela Nagel, Amy Parkhill, Jill Lavigne, Lisa Phillips, Judianne Slish, Asim Abu-Baker, Anthony Corigliano, Brooke Lowry, Andrea Traina, Christine Birnie, Marvin Pankaskie. Synchronizing Basic and Clinical Science Education at the Wegmans School of Pharmacy. Annual Convention American Association of College of Pharmacy. San Antonio, Texas, July 9-13, 2011.
  • Karl Fiebelkorn, Andy Flynn, Judianne Slish and Richard O'Brocta. New York State Hospital Pharmacy Capacity Survey-Experiential and Employment. Annual Convention American Association of College of Pharmacy. San Antonio, Texas, July 9-13, 2011.
  • When to treat Aseptic Meningitis, a review of HSV meningitis/encephalitis." Inservice, Department of Pharmacy, Highland Hosptial, March 2008.
  • Higgins N, Boston N, Catanzaro L, Slish J, O'Hara T, Hsiao C, Sulaiman A, Walsh K, and Morse G. HIV-Adherence Pharmacology Unit Coordinates Pharmacotherapy, Promotes Clinical Research and Facilitates the Medication Reconciliation Process. Presented at the NIMH/IAPAC International Conference on HIV Treatment Adherence, Jersey City, New Jersey, USA, March 8-10, 2006 Abstract P-310.
  • JC Slish, AM Redlinski, NS Boston, LM Catanzaro, CB Hsiao, A Sulaiman, GD Morse. Therapeutic Drug Monitoring (TDM) in Patients Co-infected with HIV and Hepatitis C (HCV). 45th Annual ICAAC, Washington, DC December 16-19 2005 abstract H-1904.
  • Q. Ma, D. Brazeau , B. Zingman , R.C. Reichman , M.A. Fischl , B. Gripshover , J.C. Slish , R. DiFrancesco, A. Forrest , G.D. Morse. MDR1 Single Nucleotide Polymorphisms (SNPs) in HIV-Infected Substance Users (SU) and Nonusers (NU) During Therapeutic Drug Monitoring (TDM). 45th Annual ICAAC, Washington, DC December 16-19 2005 abstract H-1907.
  • N Higgins, J Slish, L Catanzaro, NS Boston, R DiFrancesco, CB Hsiao, A Sulaiman , G Morse. National HIV Drug Interaction and Antiretroviral (ARV) Therapeutic Drug Monitoring (TDM) Registry. ASHP Clinical Midyear Meeting in Las Vegas, NV December 4-8 2005. Abstract RP353.
  • JC Slish, AM Redlinski, NS Boston, LM Catanzaro, CB Hsiao, A Sulaiman, GD Morse. Therapeutic Drug Monitoring (TDM) in Patients Co-infected with HIV and Hepatitis C (HCV). American College of Clinical Pharmacy Annual Meeting, San Francisco, CA October 23-26 2005.
  • NS Boston, JC Slish, LM Catanzaro, AM Redlinski, CB Hsiao, A Sulaiman, and GD Morse. Clinical Application of Therapeutic Drug Monitoring (TDM) in HIV/Hepatitis C (HCV) Patients. American College of Clinical Pharmacy Annual Meeting, San Francisco, CA October 23-26 2005.
  • NS Boston, LM Catanzaro, JC Slish, CB Hsiao, A Sulaiman, K Walsh, and GD Morse. HIV-Adherence Pharmacology Unit Coordinates Pharmacotherapy and Clinical Research. American College of Clinical Pharmacy Annual Meeting, San Francisco, CA October 23-26 2005.
  • NS Boston, LM Catanzaro, JC Slish, CB Hsiao, A Sulaiman, K Walsh, and GD Morse. HIV Adherence Pharmacology Unit Coordinates Pharmacotherapy and Clinical Research. Treatment and Management of HIV Infection in the United States Conference Atlanta, GA, September, 2005.
  • LM Catanzaro, NS Boston, JC Slish, A Sulaiman, CB Hsiao, GD Morse. Comprehensive Pharmacologic Evaluation for Interdisciplinary Management Strategies. Treatment and Management of HIV Infection in the United States Conference-Atlanta, GA, September, 2005.
  • JC Slish, NS Boston, LM Catanzaro, AM Redlinski, CB Hsiao, A Sulaiman, and GD Morse. Therapeutic Drug Monitoring (TDM) in HIV/Hepatitis C (HCV) Patients. Treatment and Management of HIV Infection in the United States Conference-Atlanta, GA, September, 2005.
  • J. Slish*, L. Catanzaro, K. Tooley, F. Lliguicota, R. DiFrancesco, GD. Morse. National HIV Drug Interaction and Antiretroviral (ARV) Therapeutic Drug Monitoring (TDM) Registry. 6th International Workshop on Clinical Pharmacology of HIV Therapy. Quebec, Canada. April 2005. (Abstract 5.14).
  • Ross G. Hewitt, MD, Linda M. Catanzaro, Pharm.D., Olanrewaju O. Okusanya, Pharm.D., Judianne C. Slish, Pharm.D. BCPS. Three Year Experience of ZDV/3TC/ABC + Efavirenz or ZDV/3TC/ABC + Nelfinavir for the Treatment of Antiretroviral Naïve HIV-1 Positive Patients. Infectious Diseases Society of America Annual Meeting, Boston, Massachusetts September 2004.
  • Aesha D. Alkebulan, Pharm.D.; Judianne C. Slish, Pharm.D., BCPS; Linda M. Catanzaro, Pharm.D.; JoAnne M. Stoneman, RN; Gene D. Morse, Pharm.D., BCPS, FCCP. HIV/AIDS Pharmacotherapeutic Monitoring in an Inpatient Setting. American College of Clinical Pharmacology 33rd Annual Meeting Arizona October 3-5, 2004.
  • J. Slish, L. Catanzaro, L. Esch, R. DiFrancesco, R. Hewitt, G. Morse. Clinical Application of Therapeutic Drug Monitoring Alone and Combined with Phenotypic Resistance Testing of Antiretrovirals. 5th International Workshop on Clinical Pharmacology of HIV Therapy. Rome, Italy April 2004. (Abstract 6.16).
  • Catanzaro L, Slish J, Esch L, DiFrancesco R, Maliszewski M, Hewitt R, Morse G. The Impact of an Adherence Program on Obtaining Interpretable Therapeutic Drug Monitoring of Antiretrovirals "Elements of Success: 2nd International Conference on Adherence to Antiretroviral Therapy." Dallas, Texas December 2003.
  • Judianne C. Slish, Pharm.D., Linda M. Catanzaro, Pharm.D., Lori D. Esch, Pharm.D., Francesco O. Lliguicota, B.S., Robin DiFrancesco, MBA, Ross Hewitt, M.D., Gene D. Morse, Pharm.D. Clinical Application of Therapeutic Drug Monitoring of Antiretrovirals. American College of Clinical Pharmacy. Annual Convention, Atlanta, GA November 2003.
  • Slish JC, Catanzaro L, Esch L, Lliguicota F, DiFrancesco R, Morse GD. "HIV Drug Interactions and Antiretroviral (ARV) Therapeutic Drug Monitoring (TDM) Registry: Attaining Compliance With Clinical Laboratory Improvement Act (CLIA) and the Health Insurance Portability and Accountability Act (HIPAA)." 4th International Workshop on Clinical Pharmacology of HIV Therapy. Cannes, France March 27-29, 2003. (Abstract 5.8).
  • Maponga CC, Simoyi M, Esch L, Slish JC, Hewitt RG, Reichman RC, Morse GD. "Transitioning an Established Antiretroviral Adherence-Pharmacology Unit to Developing Countries." 4th International Workshop on Clinical Pharmacology of HIV Therapy. Cannes, France March 27-29, 2003. (Abstract 1.3).
  • Maponga CC, Simoyi M, Reichman RC, Slish JC, Morse GD. "Promoting Adherence To Therapy Using Lay Community Volunteers: Experience From Urban Zimbabwe." 4th International Workshop on Clinical Pharmacology of HIV Therapy. Cannes, France. March 27-29, 2003. (Abstract # 1.2).
  • Slish JC, Estes L, Inge LD, Oyen L, Albright RC Jr., Wilson JW, Matzke GR. "Comparison of Calculated Versus In Vivo Measurement of Cefepime Among Patients Treated with Continuous Venovenous Hemodiafiltration." Platform presentation presented at Twenty-Eighth Annual Midwest Pharmacy Residents Conference. St. Paul/Minneapolis, Minnesota May 9-11, 2002.
  • Guillet R, Cole C, Slish J, and DiCenzo R. "Gentamicin Dosing in Neonates as a Function of Gestational Age and Birth Weight." Abstract, Poster presented at American Academy of Pediatrics Annual Meeting, Boston; April 2001, and Eastern States Conference. Baltimore, Maryland April 2001.
  • DiCenzo R, Forrest A, Cole C, Slish, J, Guillet R. "Population Pharmacokinetic Model and Once Daily Dosing Algorithm for Gentamicin in Neonates." The 2002 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Atlanta, Georgia, March 2002.

Grants/Research Experience

  • Project-"Perioperative and Postoperative Blood Glucose Control Guideline: Safety and Efficacy Evaluation" 2014 In Progress.
  • Project-"AKI Aminoglycoside-Containing Cement" 2013-In Progress.
  • Project-"Adherence to the University of Rochester Medical Center C. Difficile Protocol" 2013-In Progress.
  • Project:"Protease Inhibitors and Efavirenz in HIV/HCV Co-Infected Patients" 2004 - completed
  • HIV Drug Interaction and Therapeutic Drug Monitoring in HIV-infected Subjects With and Without Active Substance Abuse. Key Personnel, 5% effort, Multi-center Trial Sponsored by the National Institute for Drug Abuse (2002-2007).
  • Longitudinal Assessment of Protease Inhibitors in HIV/HCV/HBV Co-infected Patients, Primary Investigator, 15% effort, Agouron Pharmaceuticals (September 2003-2006).
  • HIV Drug Interactions and Therapeutic Drug Monitoring Registry Protocol. Co-Investigator, 5% effort, May 2002-2006.
  • Examining adherence barriers in pediatric and adolescent HIV patients, faculty consultant, 5% effort, faculty consultant, Center for Development of Human Services (CDHS) at Buffalo State College research foundation ( September 2003- June 2004).

Courses Taught

  • PHAR 5257 Pathophysiology & Therapeutics IV
    • Skin Bone and Joint Infections
    • Diabetic Foot Infections
    • Sexually Transmitted Diseases Bacterial
    • Sexually Transmitted Diseases Viral
    • Opportunistic Infections
  • PHAR 5237 Concepts In Pharmacy Practice
    • Seminar Topics
    • Counseling Video Review
    • APHA's Immunization Course
  • PHAR 5524 Drug Interaction Elective
    • Course Coordinator
    • Cytochrome P450 Drug Interactions
    • HIV Drug Interactions

Map & DirectionsA-Z Site IndexPeople Directory

Copyright © St. John Fisher College • 3690 East Avenue, Rochester, New York 14618 • (585) 385-8000
Questions/Comments? - Email the Webmaster Website Terms of Use